Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Join | Sign in
Home>News

  News Archive

4SC Strengthens Patent Protection for Lead Cancer Compound Resminostat
Wednesday, July 01, 2015
US patent for medical use in cancer and Canadian composition of matter patent granted.

Celgene Launches $1B Immunotherapy Collaboration with Juno
Wednesday, July 01, 2015
Celgene and Juno Therapeutics have launched a 10-year global collaboration to develop and commercialize cancer and autoimmune diseases immunotherapies.

Animals’ Genomic Buffers May Help Humans
Wednesday, July 01, 2015
Researchers at Duke University School of Medicine and Brigham and Women’s Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.

Personalized Screening for Ovarian Cancer
Tuesday, June 30, 2015
With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.

New Genetic Form of Obesity and Diabetes Discovered
Tuesday, June 30, 2015
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.

Potential New Class of Cancer Drugs
Tuesday, June 30, 2015
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.

EU Recommends Approval for Alexion's Rare Disease Drugs
Tuesday, June 30, 2015
Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

ReadSense, Strand Life Sciences Partner
Tuesday, June 30, 2015
Russian genomics firm ReadSense has signed a deal with Strand Life Sciences to co-develop next-generation sequencing-based tests for the diagnosis of inherited diseases including hereditary forms of epilepsy and primary immunodeficiency disorders.

More Accurate and Comprehensive Whole Genome Assembly
Tuesday, June 30, 2015
Scientists from the Icahn School of Medicine at Mount Sinai have developed a new approach to build nearly complete genomes by combining high-throughput DNA sequencing with genome mapping.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 9651
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters